2519. A Multi-national Phase 3, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10678407 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature